Ir para o conteúdo

UCSF Department of Psychiatry and Behavioral Sciences

@ucsfpsych.bsky.social did:plc:td37ll5g4w6nscd22lclr3mt

We are committed to advancing mental health across the lifespan with a mission focused on research, teaching, patient care and public service. linktr.ee/ucsfpsychiatry Social Media Disclaimer: https://psychiatry.ucsf.edu/connect

No Bluesky desde

Seguidores
231
Seguindo
48
Posts
469
Dias nos rankings
0

Resumo

UCSF Department of Psychiatry and Behavioral Sciences (@ucsfpsych.bsky.social) é um usuário do Bluesky desde 21 novembro 2024. Tem 231 seguidores, segue 48 contas e publicou 469 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in Pediatrics! Following 11,279 adolescents over 5 years, we found: 🔄 Problematic social media use & depression may reinforce each other 👧 The link was stronger among girls 🔗 tinyurl.com/DepSM26 @ameracadpeds.bsky.social

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    📱 What does the evidence show about policies to protect teens on social media? New in @jamanetworkopen.com: We reviewed 39 publications across 6 policy approaches. 🔗https://tinyurl.com/SMPolicy26

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @ajpmonline.bsky.social! 🧠Adolescents in the low-to-moderate and moderate-to-high problematic social media use trajectories had lower cognitive performance 🔗 Read here: tinyurl.com/socmind @theabcdstudy.bsky.social

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @annalsofepi.bsky.social! Among 10,735 adolescents in @theabcdstudy.bsky.social, we found that adolescents with increasing social media use are more likely to experience greater eating disorder symptoms. 🔗 Read here: tinyurl.com/EDTraj

    Ver post
  • UCSF Edward and Pearl Fein Memory and Aging Center@ucsfmac.bsky.social

    Led by Adam Boxer, MD, PhD, and colleagues, UCSF is screening participants for the Alzheimer's Tau Platform (ATP) trial, the first large-scale national study to test combination therapy targeting both amyloid and tau in early or asymptomatic Alzheimer's disease.

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.